SPDR 시리즈 신탁 - State Street SPDR S&P Pharmaceuticals ETF
US ˙ ARCA ˙ US78464A7220

SecurityXPH / SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF
InstitutionWhittier Trust Co
Latest Disclosed Ownership619 shares
Latest Disclosed Value $ 33,643
Whittier Trust Co ownership in XPH / SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF

On April 28, 2026 - Whittier Trust Co filed a 13F-HR form disclosing ownership of 619 shares of SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF (US:XPH) valued at $33,482 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 619 shares of SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF. This represents a change in shares of 0.00% during the quarter. The current value of the position is $35,308 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F SPDR S&P PHARMA ETF common 78464A722 619 0 0.00 34 -2.94 0.0004
2026-01-26 2025-12-31 13F SPDR S&P PHARMA ETF common 78464A722 619 -31 -4.77 34 9.68 0.0004
2025-10-31 2025-09-30 13F SPDR SERIES TRUST common 78464A722 650 0 0.00 32 19.23 0.0004
2025-07-30 2025-06-30 13F SPDR SERIES TRUST S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 650 -200 -23.53 26 -29.73 0.0003
2025-05-02 2025-03-31 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 850 -40 -4.49 37 -2.63 0.0005
2025-02-11 2024-12-31 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 890 0 0.00 38 -2.56 0.0005
2024-10-21 2024-09-30 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 890 0 0.00 39 11.43 0.0005
2024-07-29 2024-06-30 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 890 0 0.00 35 -7.89 0.0005
2024-05-02 2024-03-31 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 890 -5 -0.56 38 2.70 0.0006
2024-01-11 2023-12-31 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 895 30 3.47 37 8.82 0.0006
2023-10-27 2023-09-30 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 865 200 30.08 34 25.93 0.0006
2023-07-24 2023-06-30 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 665 0 0.00 27 0.00 0.0005
2023-04-21 2023-03-31 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 665 0 0.00 27 0.00 0.0005
2023-01-25 2022-12-31 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 665 0 0.00 27 0.00 0.0005
2022-10-21 2022-09-30 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 665 0 0.00 27 -3.57 0.0006
2022-07-28 2022-06-30 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 665 0 0.00 28 -6.67 0.0006
2022-04-29 2022-03-31 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 665 0 0.00 30 -3.23 0.0005
2022-01-19 2021-12-31 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 665 0 0.00 31 -3.12 0.0005
2021-11-01 2021-09-30 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 665 100 17.70 32 10.34 0.0006
2021-07-29 2021-06-30 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 565 200 54.79 29 61.11 0.0005
2021-04-26 2021-03-31 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 365 195 114.71 18 100.00 0.0003
2021-01-29 2020-12-31 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 170 0 0.00 9 28.57 0.0002
2020-10-30 2020-09-30 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 170 0 0.00 7 0.00 0.0002
2020-07-10 2020-06-30 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 170 0 0.00 7 16.67 0.0002
2020-04-27 2020-03-31 13F SPDR SER TR S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 170 5 3.03 6 -25.00 0.0002
2020-01-31 2019-12-31 13F SPDR SERIES TRUST S&P PHARMAC US LARGE-CAP EQUITIES 78464A722 165 165 8 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.